As a result of these actions, Neuralstem is asking for a declaratory judgment that the patent is unenforceable. The suit was filed in the US District Court of Maryland Southern Division.
Richard Garr, Neuralstem president & CEO, said: “We are confident that their intentional withholding of highly material information and their intent to deceive the Patent Office, will result in this patent being unenforceable.